Health16 hours ago
DEI Biopharma’s CRISPR Platform Promises Affordable, Universal Gene Therapy in fight against Sickle Cell Disease.
Ugandan biotech pioneer Dr. Matthias Magoola and DEI Biopharma have unveiled a game-changing CRISPR-based gene therapy platform for sickle cell disease. By targeting a universal genetic...
